End Nicotine Dependence Clinic
| Status: | Recruiting |
|---|---|
| Conditions: | Smoking Cessation, Tobacco Consumers |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/21/2019 |
| Start Date: | January 9, 2018 |
| End Date: | July 2021 |
| Contact: | Monica Webb Hooper, PhD |
| Email: | mwh54@case.edu |
| Phone: | 216-368-6895 |
End Nicotine Dependence (END) Clinic
The purpose of this research is to study a smoking cessation program for adult smokers in
Northeast Ohio. The study will also look at how different people respond to the program.
Northeast Ohio. The study will also look at how different people respond to the program.
Objective 1: To examine the feasibility of conducting an evidence-based, cognitive behavioral
therapy (CBT) for tobacco cessation delivered in multiple formats. Participants will have the
opportunity to receive a CBT-based tobacco intervention delivered several possible formats
(face-to-face, telephone, video-counseling) based on availability and participant
preferences. Study participants will be exposed to cognitive-behavioral cessation and relapse
prevention strategies, and discuss barriers to cessation, previous quit attempts, risky
situations, and benefits observed after quitting. Participants may also complete exercises
designed to assist cessation attempts (e.g., mental and behavioral coping skills, cognitive
reframing exercise, health benefits of cessation; and no-smoking behavioral contracts). As
supplemental treatment, participants may have the option to receive up to 8 weeks of nicotine
replacement therapy and text-messaging support.
Objective 2: To examine the rates of smoking abstinence across intervention formats.
Investigators will attempt to follow-up with participants for a 6-months after program
completion. Investigators will assess point prevalence abstinence for each intervention
delivery method.
Objective 3: To assess individual difference variables that influence outcomes. Investigators
will examine individual-difference predictors of outcomes, such as readiness to quit, social
support, distress, and environmental factors.
therapy (CBT) for tobacco cessation delivered in multiple formats. Participants will have the
opportunity to receive a CBT-based tobacco intervention delivered several possible formats
(face-to-face, telephone, video-counseling) based on availability and participant
preferences. Study participants will be exposed to cognitive-behavioral cessation and relapse
prevention strategies, and discuss barriers to cessation, previous quit attempts, risky
situations, and benefits observed after quitting. Participants may also complete exercises
designed to assist cessation attempts (e.g., mental and behavioral coping skills, cognitive
reframing exercise, health benefits of cessation; and no-smoking behavioral contracts). As
supplemental treatment, participants may have the option to receive up to 8 weeks of nicotine
replacement therapy and text-messaging support.
Objective 2: To examine the rates of smoking abstinence across intervention formats.
Investigators will attempt to follow-up with participants for a 6-months after program
completion. Investigators will assess point prevalence abstinence for each intervention
delivery method.
Objective 3: To assess individual difference variables that influence outcomes. Investigators
will examine individual-difference predictors of outcomes, such as readiness to quit, social
support, distress, and environmental factors.
Inclusion Criteria:
- Current smokers who would like help quitting (≥ 5 cigarettes per day and/or have a
breath carbon monoxide (CO) reading of ≥ 8 ppm)
- Able to speak and read English
- Able to engage using at least one of the intervention formats.
Exclusion Criteria:
- Enrollment in another cessation program
- Do not speak and read English
- Do not have access to at least one intervention format
- Have contraindications for NRT
- Do not have contact information (e.g., address, telephone number)
- Are in treatment for substance abuse (e.g., illicit drugs, alcohol abuse)
- They endorse active addiction to another substance (e.g., illicit drugs or alcohol).
- People who self-report having a severe mental illness
We found this trial at
1
site
10900 Euclid Avenue
Cleveland, Ohio 44106
Cleveland, Ohio 44106
Principal Investigator: Monica Webb Hooper, PhD
Phone: 216-368-6895
Click here to add this to my saved trials
